# CYRAMZA

NDC: 0002-7669
Generic name: ramucirumab
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140421

FDA application: BLA125477

## Active ingredients

- RAMUCIRUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-7669"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-7669
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6080942-dee6-423e-b688-1272c2ae90d4